Showing results (1-10 of 303) with videos related to
Sort By:
Pageof 31
Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society|December 12, 2022
Baroreflex-sympathoneural dysfunction characterizes at-risk individuals with preclinical central Lewy body diseasesDavid S Goldstein, Yehonatan SharabiBrain Research|October 15, 2017
The heart of PD: Lewy body diseases as neurocardiologic disordersDavid S Goldstein, Yehonatan SharabiJournal of the Neurological Sciences|July 19, 2011
Mechanisms of orthostatic hypotension and supine hypertension in Parkinson diseaseYehonatan Sharabi, David S GoldsteinJournal of the Neurological Sciences|May 3, 2011
Autonomic dysfunction in PD: a window to early detection?David S Goldstein, LaToya Sewell, Yehonatan SharabiBrain : a Journal of Neurology|March 28, 2012
Cerebrospinal fluid biomarkers of central catecholamine deficiency in Parkinson's disease and other synucleinopathiesDavid S Goldstein, Courtney Holmes, Yehonatan SharabiPharmacology & Therapeutics|June 20, 2014
Catecholamine autotoxicity. Implications for pharmacology and therapeutics of Parkinson disease and related disordersDavid S Goldstein, Irwin J Kopin, Yehonatan SharabiNeurology|October 4, 2015
Survival in synucleinopathies: A prospective cohort studyDavid S Goldstein, Courtney Holmes, Yehonatan Sharabi, et al.Autonomic Neuroscience : Basic & Clinical|January 19, 2016
DOPAL is transmissible to and oligomerizes alpha-synuclein in human glial cellsYunden Jinsmaa, Patricia Sullivan, Yehonatan Sharabi, et al.Hypertension (Dallas, Tex. : 1979)|June 5, 2003
Baroreflex failure as a late sequela of neck irradiationYehonatan Sharabi, Raghuveer Dendi, Courtney Holmes, et al.Neurochemical Research|August 26, 2017
N-Acetylcysteine Prevents the Increase in Spontaneous Oxidation of Dopamine During Monoamine Oxidase Inhibition in PC12 CellsDavid S Goldstein, Yunden Jinsmaa, Patti Sullivan, et al.Pageof 31